Please Wait.....
Report
MEA Hereditary Cancer Testing Market - Industry Trends and Forecast to 2029
Market Report I 2022-10-01 I 176 Pages I Data Bridge Market Research
Middle East and Africa hereditary cancer testing market is projected to register a CAGR of 11.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Market Segmentation:
Middle East and Africa Hereditary Cancer Testing Market, By Test Type (Multi Panel Set, and Single-Site Genetic Test) Diagnosis Type (Biopsy, Imaging, Lab Tests) Technology (Sequencing, Polymerase Chain Reaction (PCR), Microarray) Disease Type (Hereditary Breast & Ovarian Cancer Syndrome, Cowden Syndrome, Lynch Syndrome, Hereditary Leukemia And Hematologic Malignancies Syndromes, Familial Adenomatous Polyposis (FAP), Li-Fraumeni Syndrome, Vol-Hippel Lindau Disease, Multiple Endocrine Neoplasias (MEN) Syndromes) End User (Hospitals, Clinics, Laboratories, Radiology Centers, Diagnostic Centers, Others) Distribution Channel (Direct Tender, Retail Sales) Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East and Africa) Industry Trends and Forecast to 2029
Some of the factors boosting the growth of the hereditary cancer testing market are:
- Rising incidence of hereditary cancer
- Increased demand for non-invasive testing methods
Market Players:
The key market players for Middle East and Africa hereditary cancer testing market are listed below:
- Invitae Corporation
- Illumina, Inc.
- Natera, Inc.
- CENTOGENE N.V.
- 4baseCare
- Biocartis
- Fulgent Genetics
- Ambry Genetics
- BioReference
- PerkinElmer Inc.
- LifeLabs
- Abbott
- BIO-HELIX
- Cepheid
- Eurofins Scientific
TABLE OF CONTENTS
1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET 31
1.4 CURRENCY AND PRICING 33
1.5 LIMITATIONS 33
1.6 MARKETS COVERED 34
2 MARKET SEGMENTATION 37
2.1 MARKETS COVERED 37
2.2 GEOGRAPHICAL SCOPE 38
2.3 YEARS CONSIDERED FOR THE STUDY 39
2.4 DBMR TRIPOD DATA VALIDATION MODEL 40
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 43
2.6 MULTIVARIATE MODELLING 44
2.7 MARKET END USER COVERAGE GRID 45
2.8 SOURCE LIFELINE CURVE 46
2.9 DBMR MARKET POSITION GRID 47
2.10 VENDOR SHARE ANALYSIS 49
2.11 SECONDARY SOURCES 50
2.12 ASSUMPTIONS 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHT 54
4.1 PESTEL ANALYSIS 55
4.2 PORTER'S FIVE FORCES 56
5 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET: REGULATIONS 57
6 MARKET OVERVIEW 62
6.1 DRIVERS 64
6.1.1 RISING INCIDENCE OF HEREDITARY CANCER 64
6.1.2 INCREASE IN THE GERIATRIC POPULATION 64
6.1.3 RISING HEALTHCARE SPENDING 65
6.1.4 INCREASE IN AWARENESS ABOUT CANCER TESTING 65
6.2 RESTRAINTS 66
6.2.1 HIGH COST OF HEREDITARY CANCER TESTING 66
6.2.2 LACK OF SKILLED PROFESSIONALS 67
6.3 OPPORTUNITIES 67
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 67
6.3.2 INCREASED DEMAND FOR NON-INVASIVE TESTING METHODS 68
6.3.3 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS 69
6.3.4 TECHNOLOGICAL DEVELOPMENTS IN HEREDITARY CANCER TESTING PROCEDURES 69
6.4 CHALLENGES 70
6.4.1 ETHICAL CHALLENGES FACED DURING HEREDITARY CANCER TESTING 70
6.4.2 RISING COMPETITION AMONG MARKET PLAYERS 71
7 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET, BY TEST TYPE 72
7.1 OVERVIEW 73
7.2 MULTI PANEL TEST 76
7.3 SINGLE-SITE GENETIC TEST 76
8 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET, BY DIAGNOSIS TYPE 77
8.1 OVERVIEW 78
8.2 BIOPSY 81
8.2.1 NEEDLE BIOPSIES 81
8.2.2 ENDOSCOPIC BIOPSIES 81
8.2.3 LAPAROSCOPIC, THORACOSCOPIC, AND MEDIASTINOSCOPIC BIOPSY 82
8.2.4 LAPAROTOMY AND THORACOTOMY 82
8.2.5 OTHERS 82
8.3 IMAGING 82
8.3.1 MAGNETIC RESONANCE IMAGING (MRI) 83
8.3.2 COMPUTED TOMOGRAPHY (CT) SCAN 83
8.3.3 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 83
8.3.4 NUCLEAR SCAN 83
8.3.5 ULTRASOUND 83
8.3.6 X-RAYS 83
8.4 LAB TESTS 84
8.4.1 BLOOD 84
8.4.2 URINE 84
8.4.3 OTHERS 84
9 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET, BY TECHNOLOGY 85
9.1 OVERVIEW 86
9.2 POLYMERASE CHAIN REACTION (PCR) 89
9.3 SEQUENCING 89
9.4 MICRO ARRAY 90
10 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET, BY DISEASE TYPE 91
10.1 OVERVIEW 92
10.2 HEREDITARY BREAST & OVARIAN CANCER SYNDROME 95
10.3 COWDEN SYNDROME 95
10.4 LYNCH SYNDROME 96
10.5 HEREDITARY LEUKEMIA AND HEMATOLOGIC MALIGNANCIES SYNDROME 96
10.6 FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 97
10.7 LI-FRAUMENI SYNDROME 97
10.8 VON HIPPEL-LINDAU DISEASE 98
10.9 MULTIPLE ENDOCRINE NEOPLASIAS (MEN) SYNDROME 98
11 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET, BY END USER 99
11.1 OVERVIEW 100
11.2 HOSPITALS 103
11.3 CLINICS 103
11.4 DIAGNOSTIC CENTERS 104
11.5 RADIOLOGY CENTERS 104
11.6 LABORATORIES 105
11.7 OTHERS 105
12 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET, BY DISTRIBUTION CHANNEL 106
12.1 OVERVIEW 107
12.2 DIRECT TENDER 110
12.3 RETAIL SALES 110
13 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET, BY REGION 111
13.1 MIDDLE EAST AND AFRICA 112
13.1.1 SOUTH AFRICA 120
13.1.2 SAUDI ARABIA 124
13.1.3 U.A.E. 128
13.1.4 EGYPT 132
13.1.5 ISRAEL 136
13.1.6 REST OF THE MIDDLE EAST AND AFRICA 140
14 MIDDLE EAST & AFRICA HEREDITARY CANCER TESTING MARKET: COMPANY LANDSCAPE 141
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 141
15 SWOT ANALYSIS 142
16 COMPANY PROFILE 143
16.1 ABBOTT 143
16.1.1 COMPANY SNAPSHOT 143
16.1.2 REVENUE ANALYSIS 143
16.1.3 COMPANY SHARE ANALYSIS 144
16.1.4 PRODUCT PORTFOLIO 144
16.1.5 RECENT DEVELOPMENTS 144
16.2 ILLUMINA, INC. (2021) 145
16.2.1 COMPANY SNAPSHOT 145
16.2.2 REVENUE ANALYSIS 145
16.2.3 COMPANY SHARE ANALYSIS 146
16.2.4 PRODUCT PORTFOLIO 146
16.2.5 RECENT DEVELOPMENTS 147
16.3 PERKINELMER INC. (2021) 148
16.3.1 COMPANY SNAPSHOT 148
16.3.2 REVENUE ANALYSIS 148
16.3.3 COMPANY SHARE ANALYSIS 149
16.3.4 PRODUCT PORTFOLIO 149
16.3.5 RECENT DEVELOPMENTS 149
16.4 LIFELABS GENETICS 150
16.4.1 COMPANY SNAPSHOT 150
16.4.2 COMPANY SHARE ANALYSIS 150
16.4.3 PRODUCT PORTFOLIO 151
16.4.4 RECENT DEVELOPMENTS 151
16.5 EUROFINS SCIENTIFIC (2021) 152
16.5.1 COMPANY SNAPSHOT 152
16.5.2 REVENUE ANALYSIS 152
16.5.3 COMPANY SHARE ANALYSIS 153
16.5.4 PRODUCT PORTFOLIO 153
16.5.5 RECENT DEVELOPMENT 153
16.6 AMBRY GENETICS 154
16.6.1 COMPANY SNAPSHOT 154
16.6.2 REVENUE ANALYSIS 154
16.6.3 PRODUCT PORTFOLIO 155
16.6.4 RECENT DEVELOPMENTS 155
16.7 BIOCARTIS 156
16.7.1 COMPANY SNAPSHOT 156
16.7.2 REVENUE ANALYSIS 156
16.7.3 PRODUCT PORTFOLIO 157
16.7.4 RECENT DEVELOPMENTS 157
16.8 BIO-HELIX 158
16.8.1 COMPANY SNAPSHOT 158
16.8.2 PRODUCT PORTFOLIO 158
16.8.3 RECENT DEVELOPMENTS 158
16.9 BIOREFERENCE (A SUBSIDIARY OF OPKO HEALTH, INC.) (2021) 159
16.9.1 COMPANY SNAPSHOT 159
16.9.2 REVENUE ANALYSIS 159
16.9.3 PRODUCT PORTFOLIO 160
16.9.4 RECENT DEVELOPMENT 160
16.10 CENTOGENE N.V. (2021) 161
16.10.1 COMPANY SNAPSHOT 161
16.10.2 REVENUE ANALYSIS 161
16.10.3 PRODUCT PORTFOLIO 162
16.10.4 RECENT DEVELOPMENT 162
16.11 CEPHEID 163
16.11.1 COMPANY SNAPSHOT 163
16.11.2 PRODUCT PORTFOLIO 163
16.11.3 RECENT DEVELOPMENT 163
16.12 FULGENT GENETICS 164
16.12.1 COMPANY SNAPSHOT 164
16.12.2 REVENUE ANALYSIS 164
16.12.3 PRODUCT PORTFOLIO 165
16.12.4 RECENT DEVELOPMENT 165
16.13 INVITAE CORPORATION 166
16.13.1 COMPANY SNAPSHOT 166
16.13.2 REVENUE ANALYSIS 166
16.13.3 PRODUCT PORTFOLIO 167
16.13.4 RECENT DEVELOPMENT 167
16.14 NATERA, INC. (2021) 168
16.14.1 COMPANY SNAPSHOT 168
16.14.2 REVENUE ANALYSIS 168
16.14.3 PRODUCT PORTFOLIO 169
16.14.4 RECENT DEVELOPMENTS 169
16.15 4BASECARE. 171
16.15.1 COMPANY SNAPSHOT 171
16.15.2 PRODUCT PORTFOLIO 171
16.15.3 RECENT DEVELOPMENTS 172
17 QUESTIONNAIRE 173
18 RELATED REPORTS 176
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security